Switzerland has so far been spared tariff threats from the new US President Donald Trump. Nevertheless, Swiss companies are taking precautions.

After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...

Skincare product maker Galderma, and pharmaceutical company Sandoz both returned to their home market this week, bringing ...

And as you're about to notice, not only were the pharmaceutical products they created over the years similar, but Ciba, Geigy and Sandoz's histories intertwined long before their final merger in 1996.

BOUCHERVILLE, Quebec, March 18, 2025 (GLOBE NEWSWIRE) — Sandoz Canada, the leader in generic and biosimilar medicines in Canada, has signed a 10-year, long-term supply agreement with its partner ...

Despite battling for AMD market share against products from rivals Biocon ... South Africa-based Aspen Pharmaceuticals bought Sandoz’s Chinese business for $100m at the tail-end of 2023.

AstraZeneca and its wholly owned subsidiary MedImmune will leverage the Hybrozyme platform technology. ALT-B4 therapy ...

Osteoporosis drug Prolia faces intense competition as patents expire and generics launch Intense rivalry emerges in the ...

Biosimilars are essential healthcare equalizers, but their regulation is overly complicated due to lobbying by makers of ...

with Sandoz granted a first right of refusal for these markets. Avecho's CBD capsule aims to be the first pharmaceutical CBD product registered with the Therapeutic Goods Administration ("TGA") as ...